Mortality predictors in pediatric emergency department presentations: a systematic review and meta-analysis

Mohammed Alsabri1,2, Mohamed A ELKarargy3, Israa Magdy Ata4

  • 1Emergency Department, Althawara Modern General Hospital, Sanaa, Yemen. Alsabri5000@gmail.com.

BMC Emergency Medicine
|September 27, 2025
PubMed

Insights

The Pediatric Early Warning Score (PEWS) effectively identifies low-risk pediatric patients, but clinical judgment is essential for accurately assessing high-risk cases in emergency departments.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Risk Assessment
  • Health Services Research

Background:

  • Pediatric patients in emergency departments (EDs) exhibit diverse clinical presentations, necessitating systematic risk assessment for deterioration.
  • The predictive accuracy of existing mortality predictors in pediatric emergency departments (PEDs) requires thorough evaluation.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of various mortality predictors in PEDs.
  • To assess metrics including sensitivity, specificity, and diagnostic odds ratio for these predictors.

Main Methods:

  • A systematic search of multiple databases was conducted for cohort studies, case-control studies, and RCTs from 2000-2024.
  • Studies included pediatric patients (0-18 years) presenting to PEDs, analyzing mortality predictors for in-ED and short-term post-ED mortality.
  • Bivariate random-effects modeling was used to calculate pooled sensitivity, specificity, DOR, and AUC.

Main Results:

  • Analysis of 329 Pediatric Early Warning Score (PEWS) thresholds revealed an optimal cutoff of 2.189 (AUC=0.70) with high pooled sensitivity (0.95) and specificity (0.93).
  • Strong negative predictive value (NPV=0.0006) and modest positive predictive value (PPV=0.0003) were observed.
  • Significant heterogeneity (I²>99%) was noted, influenced by PEWS versions and settings; however, PEWS implementation reduced mortality without increasing ICU admissions in resource-limited settings.

Conclusions:

  • The Pediatric Early Warning Score (PEWS) serves as an effective tool for excluding low-risk pediatric patients.
  • A comprehensive approach integrating clinical judgment is crucial for accurate risk assessment in high-risk pediatric patients.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
577
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
288
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212